0001579600-16-000002.txt : 20160314
0001579600-16-000002.hdr.sgml : 20160314
20160314104456
ACCESSION NUMBER: 0001579600-16-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160314
DATE AS OF CHANGE: 20160314
EFFECTIVENESS DATE: 20160314
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: T3D Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579600
IRS NUMBER: 461674269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-235878
FILM NUMBER: 161502804
BUSINESS ADDRESS:
STREET 1: 1100 BEARGLADES LANE
CITY: RALEIGH
STATE: NC
ZIP: 27615
BUSINESS PHONE: 919-949-0517
MAIL ADDRESS:
STREET 1: 1100 BEARGLADES LANE
CITY: RALEIGH
STATE: NC
ZIP: 27615
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001579600
T3D Therapeutics, Inc.
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
919-949-0517
DELAWARE
None
None
Corporation
true
2013
John
Didsbury
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Executive Officer
Director
Promoter
Charles
Lineberry
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Barry
Buzogany
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
John
A.
Golden
68 T.W. Alexander Drive
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Pharmaceuticals
Decline to Disclose
- 06b
true
0001579600-15-000001
2015-02-26
true
true
false
100000
ROI Capital Partners, LLC
None
n/a
None
PO Box 82566
Seattle
WA
WASHINGTON
98145
All States
false
3750200
1210206
2539994
false
18
152399
true
15000
true
Represents estimated maximum potential payments, all of which are subject to future contingencies not yet met.
210000
true
false
T3D Therapeutics, Inc.
John Didsbury
John Didsbury
President and Chief Executive Officer
2016-03-11